Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
534 participants
OBSERVATIONAL
2018-03-15
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* SpO2 will be continuously recorded in order to determine the percentage of time spent with hyperoxemia.
* Patients with VAP will be prospectively identified.
* Patient characteristics and risk factors for VAP will be prospectively collected.
* Oxidant stress will be prospectively investigated in study patients: glutathion peroxidase (GPX), plasmatic superoxyde dismutase (SOD), total plasmatic antioxidant status (SAT) and urinary 8-isoprostanes will be performed at ICU admission, once a week, and at VAP occurrence.
Patients with VAP will be compared with those with no VAP
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perpetual Observational Study - Ventilator Associated Pneumonia
NCT05719259
Incidence of Dyssynchronies in Early ARDS
NCT03447288
Survival After Failed First-line Non-invasive Ventilation in Acute on Chronic Obstructive Pulmonary Disease
NCT03011853
Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS
NCT04350710
Hemodynamic Responses to Ventilator Hyperinflation Technique
NCT02739841
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Expected duration of mechanical ventilation \> 48h
* Signed informed consent
* Social insurance
Exclusion Criteria
* No informed consent
* Hyperbaric oxygen treatment
* Prisoners and patients under guardianship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Saad Nseir, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Lille
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A01934-49
Identifier Type: OTHER
Identifier Source: secondary_id
2016_73
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.